Prostate Cancer - Results from #2440

Intermediate-term oncological and functional outcomes of salvage cryotherapy for the management of prostate cancer recurrence after primary brachytherapy versus primary cryotherapy: A propensity score-matched analysis. July 21, 2023

The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial. July 20, 2023

Association between outdoor light at night and prostate cancer in the Health Professionals Follow-Up Study. July 20, 2023

Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide. July 20, 2023

Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy. July 20, 2023

Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies. July 20, 2023

Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3. July 20, 2023

Francis Medical Announces First Patient Treated in VAPOR 2 Pivotal Study for Water Vapor Ablation of Prostate Cancer July 19, 2023

Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors. July 19, 2023

Low Risk of Post-Operative Hernia Following Single-Port Robot-Assisted Radical Prostatectomy: A Report from the Single-Port Advanced Research Consortium (SPARC). July 19, 2023

The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. July 19, 2023

PARP Inhibitor Combinations in First Line mCRPC: A Systematic Review and Meta-Analysis. July 19, 2023

Explainable ML models for a deeper insight on treatment decision for localized prostate cancer. July 19, 2023

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC. July 18, 2023

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy. July 18, 2023

Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer. July 18, 2023

Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. July 18, 2023

Telehealth use and perceptions among prostate cancer survivors. July 18, 2023

Engaging disparities in prostate cancer: Piloting an interactive, virtual workshop to educate providers on shared decision-making for underserved populations. July 17, 2023

Advances in the treatment of metastatic prostate cancer. July 17, 2023

Page 123 of 1439